SUMMARY Our present understanding of the aetiology and pathogenesis of multiple sclerosis is discussed in relation to the views of Sir William Gowers. He perceived that both environmental and genetic factors might be implicated in the aetiology of the disease. Evidence for the former was first reported in 1903, but has become convincing only in the past 20 years; the nature of the environmental factor remains obscure. Evidence for a genetic influence on susceptibility has accumulated since the 1 930s, the most compelling coming from the recent Canadian twin study. The number and mode of operation of the genetic factors is still uncertain, but there is evidence for the implication of genetically controlled cellular immune mechanisms in the pathogenesis of the disease. The precise relationship between transient changes in immunological status and the development of new lesions has yet to be defined; magnetic resonance imaging (MRI) promises to play a significant role in this analysis because of its sensitivity in detecting abnormalities in multiple sclerosis. MRI is not in itself specific; it is probable that the similar appearances in multiple sclerosis and cerebral vascular disease both derive at least in part from the influence of astrocytic gliosis on proton content and distribution. The significance of the gliosis is uncertain. Gowers believed that the primary defect in multiple sclerosis lay in the astrocyte. Recent observations on the immunological functions of this cell in vitro suggest that it could be involved early in the pathogenesis of the lesion.
The title of this review is a quotation from the second edition of Gowers' Manual ofDiseases of the Nervous System published in 1893.' It is as apt a beginning today for a discussion of the cause and the nature of multiple sclerosis as it was then. What strikes the modern reader of the Manual is the precision of Gowers' observations, the elegance of the language in which he describes them, and his range. He encompassed not only clinical description and the pathology of the nervous system, but much more in medicine besides. His haemocytometer was in use until our own day and his Manual and Atlas of Ophthalmoscopy2 established the role of the ophthalmoscope not only in neurology but in general medicine as well: there one reads descriptions of the retinopathies of uraemia, diabetes and leukaemia, of retinal tubercles and of what we would now recognise as acute ischaemic optic Based on the Ninth Gowers Memorial Lecture. Gowers used the term "insular" instead of "multiple" sclerosis but I have preferred to use the modern term throughout.
former pupils, in the same volume of the Review of Neurology and Psychiatry which contained the medical version of Gowers' paper on musical notation.
Bramwell reviewed his own experience in private and hospital practice in Edinburgh and compared it with the recently published experience of a group of neurologists in New York. One in 58 of Bramwell's patients had multiple sclerosis compared with one in 219 of the pooled American cases. Bramwell was aware of the possible sources of error in comparisons of this kind, but concluded that the difference in frequency between the two places was real.
The next report of a possible geographical difference came from within the United States. In 1922 Davenport8 noted that multiple sclerosis was more common as a defect of drafted men from the northern States than the southern. A new attempt to define the influence of location on risk was made9 in 1950 when mortality data again showed a higher risk in northern than southern states.9 This trend was soon confirmed by careful prevalence studies. 0 Unexpectedly low frequency of multiple sclerosis was also found in South Africa.1 There was now an explosion of epidemiological studies. They led to the general conclusion that for northern European Caucasoid populations, the risk of developing multiple sclerosis increases as one goes further from the Equator in both the northern and the southern hemispheres: multiple sclerosis is more common in Scotland (where it approaches 200 per 100,000)12 -14 than in the south of England'5 In summary, the balance of evidence suggests that there is an environmental factor in the cause of multiple sclerosis. The working hypothesis is that it is infective but the epidemiological evidence is not conclusive. Neither is there direct confirmation of infection.
The mystery of the origin of multiple sclerosis The question has been reviewed elsewhere.29 Suffice it to say that a disease resembling multiple sclerosis has not been transferred from man to animals, that the same virus has not been isolated from different cases in different centres, and that the raised titre of antibodies against measles found in groups of patients with multiple sclerosis is not specific either to measles or to multiple sclerosis. Finally, the virus-like particles sometimes reported in multiple sclerosis brain can, with one possible exception, be accounted for in other ways. 30 
Genetic factors
In my account of the epidemiology of multiple sclerosis I have so far ignored an important point: for some races the risk of developing the disease is low and little influenced by latitude. Multiple sclerosis is rare or absent in the Bantu and appears to be rare in the Eskimo"7 and the Hungarian gypsy.3' The gypsies are racially distinct from the Caucasoids in Hungary, having migrated from north India to the Balkans in the second century and then to the rest of Europe about 500 years ago.32 In the Caucasoids the prevalence of multiple sclerosis is 37 per 100,000 whereas in the gypsies only two cases have been identified in all the neurological departments of the five Transdanubian counties serving a population of 110,000 gypsies. 3' Since the Hungarian figures are based on hospital statistics it will be important to determine whether the difference is confirmed by mortality and prevalence data based on systematic case ascertainment.
The best studied non-Caucasoid population is the Japanese. All investigations have shown that the prevalence is much lower than in Caucasoids living at comparable latitudes. 33 The prevalence in Sapporo (430 north) for example is 2:100,000 and in Boston, USA (420 north) is 41 per 100,000. 15 A particularly interesting study has been carried out on the west coast of the United States.34 The prevalence in Los Angeles in Caucasoids is 21-6 per 100,000; it rises to 68i7 in Washington State. In the Japanese it is only about 6 per 100,000 in both regions. A low risk (based on mortality data) is also seen in the Chinese25 but what makes the Japanese data especially interesting is that unlike the Chinese, they have little tendency to remain in fairly closed ethnic groups in these regions, that is they more nearly share the environment of the Europeans amongst whom the risk is so much higher. 34 The evidence suggests that there is a protective genetic influence in orientals.
Gowers' considered the genetic component in the aetiology of multiple sclerosis in the Manual': "direct heredity.... is quite exceptional; indirect inheritance is more common, shown by a family history of insanity, epilepsy, or some form of chronic paralysis". He does not enlarge on the nature of "indirect inher-115 itance" but the context suggests that he believed that there exists some general kind of genetic predisposition to neurological disease. In 1908 he was one of the opening speakers at a symposium held at the Royal Society of Medicine on heredity in disease, but he did not develop his views either on the nature of indirect inheritance or on the genetic factor in the aetiology of multiple sclerosis. Indeed, he commented that multiple sclerosis is "another affection in which heredity might be expected, according to one view of its nature, but no facts have suggested it".35 Though excited by the scientific study of heredity, he thought that at that time the study of genetics in human disease was "still at the stage of random observation"."
And thus it remained in relation to multiple sclerosis until the 1930s when Curtius36 made a good case for a significant familial incidence of the disease. Pratt et al37 reviewed in 1951 the world literature and added further cases of their own, recording that in a total of 310 cases the familial incidence was 6-5%. Many reports of familial multiple sclerosis followed. In Northern European Caucasoids the overall familial incidence turns out to be roughly 10%.3839
Stronger evidence for a genetic factor comes from the study of twins. A number of studies have suggested that it is more common for both of a pair of twins to develop multiple sclerosis if they are monozygotic than if they are not. The data have been reviewed recently.39 The incidence of concordance varies between different populations but overall the concordance rate does seem to be higher in the monozygotic twins (29%) than in the dizygotic (13%). However studies of concordance for disease in twins are usually subject to bias; concordant pairs are more likely to be identified than discordant.39 The systematic study that Dr George Ebers40 is carrying out in Canada is therefore of special interest. He and his colleagues contacted 5,000 patients with multiple sclerosis and enquired of each whether he or she had a twin. The incidence of twinning was 1/80, the expected incidence in the general population, which suggests that the risk of ascertainment bias has been minimised. They then personally examined every living twin. About 1:3 of the monozygotic pairs were concordant compared with 1:40 of the dizygotic pairs. Moreover this low concordance in the non-identical twins was similar to that for siblings, amongst whom, as we have just seen, the risk is higher than in the general population. These observations provide strong evidence for the implication of a genetic factor in the aetiology of multiple sclerosis. The HLA system It has become clear that there is an association between multiple sclerosis and the 6th chromosome and in particular with the HLA region which is concerned with the genetic control of immune mechanisms. The The question now arises whether DR2 is the critical factor which confers susceptibility to multiple sclerosis. The answer is almost certainly not, for several reasons. First, as I have just shown, the association is not universal. Secondly, in familial multiple sclerosis there is less haplotype sharing than would be expected from the population studies, although there is more than would be expected from the relationships between affected individuals.5 52 Thirdly, if one accepts at face value the Hungarian data30 one finds a remarkable thing. As already mentioned, the prevalence of multiple sclerosis in the Caucasoids is 37 per 100,000 and in the gypsies it appears to be only 2 per 100,000. The incidence of DR2 in the Caucasoids is of the expected order: 19 5% in the controls and 42-7% in the patients with multiple sclerosis; but in the control gypsy population the incidence of DR2 is very McDonald high indeed (56.5%) yet the prevalence of the disease is very lOW.3132 The fact that both the known cases are DR2 positive is unhelpful, because of the small numbers. Finally, in a twin study carried out in the USA there were two pairs of non-identical twins concordant for multiple sclerosis; in both pairs only one was Dw2 positive. 53 The first conclusion that can be drawn from this mass of apparently discordant data is that the frequency with which an association is found between the HLA system and multiple sclerosis suggests that it has some significance. Secondly, Dw2 and DR2 are in themselves neither necessary nor sufficient to lead to the development of the disease. What then might the significance of the various associations be? One possibility is that each is conferring susceptibility on its own population and that the environmental factor is different in different regions. The Hungarian data would be hard to reconcile with this interpretation. An alternative possibility is that DR2 and DR4 are acting as markers in their respective populations for a common, hitherto unidentified single susceptibility gene in the HLA region; there are after all an enormous number of candidates. The D region is the subject of intensive investigation at present. There are now 99 specificities recognised serologically and 25 by cell typing.54 The great majority have still to be examined in relation to multiple sclerosis. Several investigators5556 have argued for the view that there is a single susceptibility gene, and indeed for its being rather common and dominantly inherited,56 the low incidence of the disease being explained by variations in "dose" of the environmental factor and the age at which it is received.
There is a third possibility: that more than one genetic factor is involved. There are now several reports suggesting that such is the case. Two loci within the HLA region concerned with the control of polymorphisms in the complement pathways have been implicated. An Figure la shows an x-ray CT scan from a patient with multiple sclerosis.
Regions of low attenuation are visible in the white matter around the ventricles. An MRI scan using a spin-echo sequence (fig 1 b) shows that the periventricular abnormalities are more extensive. We have seen such changes in 59 of 60 consecutive patients with 118 The mystery of the origin of multiple sclerosis clinically definitive multiple sclerosis aged 17 to 70 years (mean 38)." In addition there is a discreet lesion in the frontal lobe which had not been suspected from the x-ray scan. We have not seen regions of altered signal from the periventricular region in 36/37 healthy control individuals aged 19 to 62 years (mean 38) (fig  lc) , although in keeping with the occasional surprise discovery of the pathological changes of multiple sclerosis at necropsy7879 one apparently healthy control subject showed MRI appearances indistinguishable from those of multiple sclerosis. Others have reported periventricular changes in individuals over the age of 60.80 Such dramatic pictures serve to remind the modern neurologist that abnormalities in the periventricular region are characteristic of multiple sclerosis.
Hallervorden8" went so far as to say that if they were not present at necropsy, the diagnosis should be in doubt. It The question now is whether it is possible positively to identify new lesions. Certainly multiple abnormalities may be seen in patients having their first clinical episode suggestive of multiple sclerosis. We have seen multiple cerebral lesions in 17 of 28 patients with isolated optic neuritis and in a similar proportion of patients with isolated acute brainstem symptoms. It is tempting to suggest that the presence of lesions remote from the site related to the symptoms indicates that there have been previous silent episodes of neurological damage and that the patient already has multiple sclerosis. Such a conclusion is premature. It is possible that in some of these patients the optic neuritis or the brain symptoms were the sole symptomatic expression of a more widespread but nevertheless monophasic pathological process. Our serial study of patients with isolated symptoms should help to resolve this problem.
One of the first priorities of the MRI group at Queen Square has been to look at the specificity of the changes for multiple sclerosis. 77 The diffuse periventricular changes and focal lesions seen in CT scans of patients with multiple sclerosis resemble those found in patients with evidence of diffuse cerebral vascular disease. We therefore investigated 23 patients with cerebral vascular disease aged 23 to 80 years (mean 61 years) including patients with late onset epilepsy and CT scan evidence of lesions consistent with lacune, acute stroke, transient global amnesia, and Binswanger's disease (cerebral vascular disease, 119 hypertension and dementia). All showed focal lesions, some small and indistinguishable from the focal lesions seen in multiple sclerosis (fig lb) others larger and corresponding with the territory of medium and large cerebral vessels. Nineteen of the 23 showed periventricular changes (fig 1) which in some patients appeared to be smoother in outline than those of multiple sclerosis, but in others were indistinguishable from them.
What do the MRI abnormalities represent? Is it oedema, which occurs in the acute lesions of both multiple sclerosis and vascular disease? Oedema alters the MRI signal, but cannot account for the changes in the chronic lesions. Is it, so to speak, myelin loss? Probably not, since it seems that myelin-bound protons contribute relatively little to the MRI signal from normal brain.83 Is it astrocytic gliosis, which is vigorous in both multiple sclerosis and vascular disease? I would like to look at this possibility a little more closely.
Figure 2a from a patient with multiple sclerosis is a myelin preparation from the frontal lobe. An adjacent section stained for glial fibrils (fig 2b) reveals the intensity of the astrocytic gliosis. Figure 2c shows a myelin preparation from the occipital lobe in a patient with Binswanger's disease and fig 2d shows the glial preparation. The changes are similar to those in multiple sclerosis. Microscopically however there are important differences;84 in multiple sclerosis there is a relative preservation of axons whereas in Binswanger's disease the picture is purely degenerative. The common ground between the lesions of multiple sclerosis and Binswanger's disease is the gliosis. The replacement of myelin by astrocytic processes would increase the water content per unit volume and thus alter the MRI signal. It is also conceivable that the signal may be modified by changes in the macromolecular environment provided by the glial fibrils.
There is perhaps some danger of expecting too much of MRI too soon. Specificity is one problem: quantitation of the changes in the brain is another which urgently needs to be solved before MRI can be used in one of its potentially most useful roles, that of monitoring treatment. These problems can be overcome and in other respects it is hard to underestimate its importance. Existing techniques offer the possibility of new clinico-pathological insights for example into the mechanism of the memory defects which are common even early in the course of multiple sclerosis,85 and into the affection of the sense of smell. The distribution of the MRI changes suggests that structures mediating olfaction may be involved in multiple sclerosis. Standard texts make little reference to the possibility, but Gowers records that the olfactory "nerve" (in reality the tract) is often abnormal.' Dr F Scaravilli and I (unpublished) have been able-to confirm readily the presence of Cruveilhier's "degeneration grise" in the olfactory tract where there is extensive loss of myelin histologically. Although patients rarely complain of abnormalities of the sense of smell, Pinching86 in the course of a study undertaken for another purpose, found definite abnormalities in 15 of 22 patients with multiple sclerosis.
A third way in which MRI promises to be helpful is in elucidating the nature and sequence of events during the development of the plaque. There is some evidence that the vessels in the plaque are abnormally permeable: CT scans may show enhancement with iodine-containing agents, and there is leakage of trypan blue into plaques at necropsy.87 In the retina too there is evidence of abnormal permeability. In a recent investigation sheathing (the ophthalmoscopic sign of perivascular cuffing) of the peripheral retinal vessels was observed in 14 of 50 consecutive patients with acute isolated optic neuritis persenting to the Moorfields Eye Hospital.88 At fluorescein angiography, the dye leaked from the sheathed segments of the vessels. The timing of the permeability changes in relation to the evolution of the lesion is however not known. The development of contrast agents such as those recently used in the study of tumours by the Hammersmith group89 raises the possibility of serial studies of the blood-brain barrier during life in multiple sclerosis. Looking further to the future, the newest technical advances indicate that it may be possible soon to study metabolism by NMR spectroscopy in focal regions of the individual patient's brain selected from magnetic resonance images of it.
To return to the pathogenesis of multiple sclerosis, there is, in summary, good evidence for the existence of immunological abnormalities in patients with the disease, but it is not established whether the tissue damage is actually produced immunologically or whether, as some have suggested, the immunological changes are a consequence of demyelination produced in some other way.90 Demyelination can be produced by allergic means, most notably in experimental allergic encephalomyelitis. In an important recent experiment Watanabe et a!9' have discovered a mechanism by which experimental viral infection can lead to the secondary development, after a delay and in the absence of recoverable virus, of allergic demyelination of the central nervous system. This is a potentially important model with which to explore the pathogenesis of multiple sclerosis.
Gowers developed his ideas about pathogenesis at some length in the Manual,1 and concluded that multiple sclerosis was primarily a disorder of the neuroglia. "It is" he said "essentially a process of morbid growth but may sometimes commence as an interstitial inflammation." This quotation comes from the unpublished third edition of Vol. II (sadly now missMcDonald ing, though the relevant page is reproduced in facsimile in Critchley's biography6). In this manuscript he goes further. He notes "the tendency of residual embryonal tissue to overgrow in adult life" and suggests "that the islets of sclerosis may start from points of developmental origin. " The idea of a neuroglial origin for multiple sclerosis derives originally from Rindfleisch92 and Charcot93 and may come as a surprise to the modern neurologist for whom research on multiple sclerosis has long focused on myelin. But as a comparison of figs 2a and b shows, glial proliferation is as striking as demyelination. It is generally assumed that the proliferation is simply a consequence of the myelin loss, but recent experiments suggest that this may be too simple a view.
Different glial cell types can now be identified using specific antibody markers combined with fluorescent dyes9495 and can be grown in 99% pure culture. It is thus feasible to investigate the properties of individual types of cell. Fontana et a!9697 have used these techniques to explore the relationship between astrocytes and the immune system. In culture they mixed rat astrocytes with rat T-lymphocytes from a line which had been sensitised to myelin basic protein. 
